StockData
Shattuck Labs, Inc. logo

Shattuck Labs, Inc. (STTK) stock

STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$4.65−0.16 (-3.33%)

Close on Nov 13, 2026Market cap $466.69MP/E –Yield –

Shattuck Labs operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Shattuck Labs's operating cash flow for the twelve months ending Sep 30, 2026 was -$49.57M. For fiscal 2025 it was -$39.88M. The highest annual figure on record is -$20.98M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$39.88M–
FY2024Dec 31, 2024-$60.52M–
FY2023Dec 31, 2023-$81.23M–
FY2022Dec 31, 2022-$94.50M–
FY2021Dec 31, 2021-$57.12M–
FY2020Dec 31, 2020-$33.66M–
FY2019Dec 31, 2019-$20.98M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$17.47M–
Q2 FY2026Jun 30, 2026-$10.19M–
Q1 FY2026Mar 31, 2026-$13.42M–
Q4 FY2025Dec 31, 2025-$8.49M–
Q3 FY2025Sep 30, 2025-$8.93M–
Q2 FY2025Jun 30, 2025-$10.43M–
Q1 FY2025Mar 31, 2025-$12.03M–
Q4 FY2024Dec 31, 2024-$17.37M–
Q3 FY2024Sep 30, 2024-$16.07M–
Q2 FY2024Jun 30, 2024-$10.92M–
Q1 FY2024Mar 31, 2024-$16.16M–
Q4 FY2023Dec 31, 2023-$19.42M–
Q3 FY2023Sep 30, 2023-$16.73M–
Q2 FY2023Jun 30, 2023-$18.62M–
Q1 FY2023Mar 31, 2023-$26.46M–
Q4 FY2022Dec 31, 2022-$23.84M–
Q3 FY2022Sep 30, 2022-$28.06M–
Q2 FY2022Jun 30, 2022-$16.32M–
Q1 FY2022Mar 31, 2022-$26.28M–
Q4 FY2021Dec 31, 2021-$18.72M–
Q3 FY2021Sep 30, 2021-$12.99M–
Q2 FY2021Jun 30, 2021-$14.34M-756.2%
Q1 FY2021Mar 31, 2021-$11.07M–
Q4 FY2020Dec 31, 2020-$14.04M–
Q3 FY2020Sep 30, 2020-$11.35M–
Q2 FY2020Jun 30, 2020$2.19M–
Q1 FY2020Mar 31, 2020-$10.45M–
Q4 FY2019Dec 31, 2019-$7.62M–

More Shattuck Labs figures

See a number that looks wrong?